Works matching IS 13419625 AND DT 2024 AND VI 29 AND IP 12


Results: 25
    1

    Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1785, doi. 10.1007/s10147-024-02643-8
    By:
    • Nakashima, Kazuhisa;
    • Yokomizo, Ayako;
    • Murakami, Michiyasu;
    • Okita, Kenji;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi
    Publication type:
    Article
    3

    List of reviewers 2023–2024.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1999, doi. 10.1007/s10147-024-02641-w
    Publication type:
    Article
    4

    Conversion surgery for esophageal and esophagogastric junction cancer.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1777, doi. 10.1007/s10147-024-02639-4
    By:
    • Shoji, Yoshiaki;
    • Kanamori, Kohei;
    • Koyanagi, Kazuo;
    • Otsuka, Tetsuya;
    • Nakashima, Rie;
    • Tajima, Kohei;
    • Ogimi, Mika;
    • Ninomiya, Yamato;
    • Yamamoto, Miho;
    • Kazuno, Akihito;
    • Nishi, Takayuki;
    • Mori, Masaki
    Publication type:
    Article
    5

    Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1946, doi. 10.1007/s10147-024-02637-6
    By:
    • Yamamoto, Yutaka;
    • Fujimoto, Saizo;
    • Hashimoto, Mamoru;
    • Minami, Takafumi;
    • Fukuokaya, Wataru;
    • Yanagisawa, Takafumi;
    • Saruta, Masanobu;
    • Takahara, Kiyoshi;
    • Nishimura, Kazuki;
    • Tsujino, Takuya;
    • Nakamori, Yuta;
    • Hashimoto, Takeshi;
    • Kimura, Takahiro;
    • Shiroki, Ryoichi;
    • Azuma, Haruhito;
    • Ohno, Yoshio;
    • Fujita, Kazutoshi
    Publication type:
    Article
    6

    Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1937, doi. 10.1007/s10147-024-02636-7
    By:
    • Kato, Minoru;
    • Taoka, Rikiya;
    • Miki, Jun;
    • Saito, Ryoichi;
    • Fukuokaya, Wataru;
    • Matsui, Yoshiyuki;
    • Yamamoto, Shoma;
    • Matsue, Taisuke;
    • Hatakeyama, Shingo;
    • Kawahara, Takashi;
    • Matsuda, Ayumu;
    • Kawai, Taketo;
    • Sazuka, Tomokazu;
    • Sano, Takeshi;
    • Urabe, Fumihiko;
    • Kashima, Soki;
    • Naito, Hirohito;
    • Murakami, Yoji;
    • Miyake, Makito;
    • Daizumoto, Kei
    Publication type:
    Article
    7

    Diagnostic performance of TILs–US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1860, doi. 10.1007/s10147-024-02634-9
    By:
    • Shigematsu, Hideo;
    • Fukui, Kayo;
    • Kanou, Akiko;
    • Yokoyama, Erika;
    • Tanaka, Makiko;
    • Fujimoto, Mutsumi;
    • Suzuki, Kanako;
    • Ikejiri, Haruka;
    • Amioka, Ai;
    • Hiraoka, Emiko;
    • Sasada, Shinsuke;
    • Emi, Akiko;
    • Nakagiri, Tetsuya;
    • Arihiro, Koji;
    • Okada, Morihito
    Publication type:
    Article
    8
    9

    First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1825, doi. 10.1007/s10147-024-02632-x
    By:
    • Oridate, Nobuhiko;
    • Takahashi, Shunji;
    • Tanaka, Kaoru;
    • Shimizu, Yasushi;
    • Fujimoto, Yasushi;
    • Matsumoto, Koji;
    • Yokota, Tomoya;
    • Yamazaki, Tomoko;
    • Takahashi, Masanobu;
    • Ueda, Tsutomu;
    • Hanai, Nobuhiro;
    • Yamaguchi, Hironori;
    • Hara, Hiroki;
    • Yoshizaki, Tomokazu;
    • Yasumatsu, Ryuji;
    • Nakayama, Masahiro;
    • Shiga, Kiyoto;
    • Fujii, Takashi;
    • Mitsugi, Kenji;
    • Takahashi, Kenichi
    Publication type:
    Article
    10
    11

    Lateral node metastasis in low rectal cancer as a hallmark to predict recurrence patterns.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1896, doi. 10.1007/s10147-024-02630-z
    By:
    • Shinto, Eiji;
    • Ike, Hideyuki;
    • Ito, Masaaki;
    • Takahashi, Keiichi;
    • Ohue, Masayuki;
    • Kanemitsu, Yukihide;
    • Suto, Takeshi;
    • Kinugasa, Tetsushi;
    • Watanabe, Jun;
    • Hida, Jin-ichi;
    • Itabashi, Michio;
    • Ozawa, Heita;
    • Nozawa, Hiroaki;
    • Hashiguchi, Yojiro;
    • Hase, Kazuo;
    • Sugihara, Kenichi;
    • Ajioka, Yoichi
    Publication type:
    Article
    12
    13

    Real-world application of comprehensive genomic profiling for gynecological malignancies: a multicenter observational study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1967, doi. 10.1007/s10147-024-02628-7
    By:
    • Fukuda, Mayu;
    • Yamanoi, Koji;
    • Hayashi, Nobutaka;
    • Kotani, Yasushi;
    • Yamano, Kazuki;
    • Matsumoto, Hisanori;
    • Ashihara, Takahito;
    • Abiko, Kaoru;
    • Yamanishi, Yukio;
    • Iemura, Yoko;
    • Taki, Mana;
    • Murakami, Ryusuke;
    • Horie, Akihito;
    • Yamaguchi, Ken;
    • Hamanishi, Junzo;
    • Mandai, Masaki
    Publication type:
    Article
    14
    15

    Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1887, doi. 10.1007/s10147-024-02626-9
    By:
    • Kasai, Shunsuke;
    • Kagawa, Hiroyasu;
    • Hatakeyama, Keiichi;
    • Shiomi, Akio;
    • Manabe, Shoichi;
    • Yamaoka, Yusuke;
    • Tanaka, Yusuke;
    • Igaki, Takahiro;
    • Nagashima, Takeshi;
    • Ohshima, Keiichi;
    • Urakami, Kenichi;
    • Akiyama, Yasuto;
    • Kinugasa, Yusuke;
    • Yamaguchi, Ken
    Publication type:
    Article
    16

    Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1850, doi. 10.1007/s10147-024-02625-w
    By:
    • Mitsuyoshi, Ayumu;
    • Nagahashi, Masayuki;
    • Kanaoka, Haruka;
    • Oshiro, Aoi;
    • Togashi, Yusa;
    • Hattori, Akira;
    • Tsuchida, Junko;
    • Higuchi, Tomoko;
    • Nishimukai, Arisa;
    • Murase, Keiko;
    • Takatsuka, Yuichi;
    • Miyoshi, Yasuo
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Out-of-pocket fertility preservation expenses: data from a Japanese nationwide multicenter survey.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1959, doi. 10.1007/s10147-024-02614-z
    By:
    • Ono, Masanori;
    • Takai, Yasushi;
    • Harada, Miyuki;
    • Horie, Akihito;
    • Dai, Yidan;
    • Kikuchi, Eiji;
    • Miyachi, Mitsuru;
    • Yamamoto, Tetsuya;
    • Fujii, Nobuharu;
    • Kajiyama, Hiroaki;
    • Manabe, Atsushi;
    • Yasuoka, Toshiaki;
    • Katsuragi, Shinji;
    • Mekaru, Keiko;
    • Maezawa, Tadashi;
    • Horage, Yuki;
    • Kataoka, Shinsuke;
    • Nakayama, Robert;
    • Nakajima, Takako Eguchi;
    • Kimura, Fuminori
    Publication type:
    Article
    24

    Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1878, doi. 10.1007/s10147-024-02613-0
    By:
    • Yamamoto, Yoshiyuki;
    • Yukami, Hiroki;
    • Yamaguchi, Tatsuro;
    • Ohori, Hisatsugu;
    • Nagasu, Sachiko;
    • Kagawa, Yoshinori;
    • Sugimoto, Naotoshi;
    • Sonoda, Hiromichi;
    • Yamazaki, Kentaro;
    • Takashima, Atsuo;
    • Okuyama, Hiroyuki;
    • Hasegawa, Hiroko;
    • Kondo, Chihiro;
    • Baba, Eishi;
    • Matsumoto, Toshihiko;
    • Kawamoto, Yasuyuki;
    • Kataoka, Masato;
    • Shindo, Yoshiaki;
    • Ishikawa, Toshiaki;
    • Esaki, Taito
    Publication type:
    Article
    25

    Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1916, doi. 10.1007/s10147-024-02612-1
    By:
    • Yoshimura, Akihiro;
    • Kato, Taigo;
    • Nakai, Yasutomo;
    • Tsujihata, Masao;
    • Toyoda, Shingo;
    • Sato, Mototaka;
    • Matsuzaki, Kyosuke;
    • Nakata, Wataru;
    • Takao, Tetsuya;
    • Inoguchi, Syunsuke;
    • Okuda, Yohei;
    • Yamamichi, Gaku;
    • Ishizuya, Yu;
    • Yamamoto, Yoshiyuki;
    • Hatano, Koji;
    • Kawashima, Atsunari;
    • Takada, Shingo;
    • Inoue, Hitoshi;
    • Nishimura, Kensaku;
    • Miyake, Osamu
    Publication type:
    Article